Value Added Abstract - (2020) Volume 0, Issue 0
The current researcher has conceptualized and developed the new, or third, mode of action pathway represented by “site attachment inhibition (or, negation of cellular attachment by infective agents).” The current author anticipates site attachment inhibition therapeutics to include: (A) drug (medication) based therapies in treatment of established infections; (B) new generation immunization methods (as preventative treatment) utilizing stem cell based treatment (including prenatal and earlier, spanning back to oogenesis and spermatogenesis) termed stc based immunization in previous publications; and, (C) other forms including waveform (E.g. electromagnetic radiation) based treatment. Immunizations are also (in addition to other human medicines) used in veterinary science in a form converted to that being suitable for the given animal species. The current author is exploring the application of site attachment inhibition in veterinary science. Of note is the use of Rhesus monkey in development of polio cure. Furthermore, SIVs potential use as of interest in knockout studies similar to that with humans in achieving immunity (resistance) to HIV.
